Clinical trial
A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the…
NCT00255983 · Replidyne, Industry · Terminated
Key facts
| NCT number | NCT00255983 |
|---|---|
| Title | A Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil In the Treatment of Chronic Bronchitis |
| Official title | Prospective, Randomized, Double-Blind Trial to Evaluate the Efficacy and Safety of Faropenem Medoxomil 600 mg PO, BID for 5 Days Versus Placebo In the Treatment of Acute Exacerbation of Chronic Bronchitis |
| Lead sponsor | Replidyne, Industry |
| Collaborators | INC Research Limited Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Chronic Bronchitis |
| Intervention type | Drug |
| Interventions | Faropenem medoxomil, placebo |
| Enrollment | 491 |
| Start date | Dec 1, 2005 |
| Primary completion | May 1, 2008 |
| Completion | Jun 1, 2008 |
| First posted | Nov 21, 2005 |
| Last update posted | Jun 3, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: